Effect of glucose degradation products, glucose-containing dialysate and icodextrin on AQP1 and eNOS expression in cultured endothelial cells

Journal of Nephrology

Volumn 22, Issue 1, 2009, Pages 117-122

  Lin, Xinghui ^a   Amore, Alessandro ^b   Loiacono, Elisa ^b   Balegno, Sabrina ^b   Manniello, Daniela ^b   Peruzzi, Licia ^b   Camilla, Roberta ^b   Minieri, Valentina ^b   Daprà, Valentina ^b   Qian, Jiaqi ^a   Coppo, Rosanna ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Aquaporin 1; Biocompatibility; Endothelial NO synthase; Glucose degradation products; Icodextrin; Peritoneal dialysis

Indexed keywords

AQUAPORIN 1; DIALYSIS FLUID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FURFURAL; GLUCOSE DEGRADATION PRODUCT; ICODEXTRIN; MESSENGER RNA; METHYLGLYOXAL; AQP1 PROTEIN, MOUSE; GLUCAN; GLUCOSE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; GENE EXPRESSION; INCUBATION TIME; MOUSE; NONHUMAN; PERITONEAL DIALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAFILTRATION; UPREGULATION; ANIMAL; ANIMAL MODEL; CYTOLOGY; DOSE RESPONSE; METABOLISM; VASCULAR ENDOTHELIUM;

ANIMALS; AQUAPORIN 1; CELL LINE; DIALYSIS SOLUTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FURALDEHYDE; GLUCANS; GLUCOSE; MICE; MODELS, ANIMAL; NITRIC OXIDE SYNTHASE TYPE III; PERITONEAL DIALYSIS; PYRUVALDEHYDE; RNA, MESSENGER;

EID: 66349085129     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ni J, Verbavatz JM, Rippe A, et al. Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis. Kidney Int. 2006;69:1518-1525.
2. Lai KN, Li FK, Lan HY, et al. Expression of aquaporin-1 in human peritoneal mesothelial cells and its upregulation by glucose in vitro. J Am Soc Nephrol. 2001;12:1036-1045.
3. Devuyst O, Nielsen S, Cosyns JP, et al. Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum. Am J Physiol. 1998;275:H234-H242.
4. Bussolino F, De Rossi M, Sica A, et al. Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. J Immunol. 1993;147:2122-2129.
5. Wieslander AP, Deppisch R, Svensson E, Forsback G, Speidel R, Rippe B. In vitro biocompatibility of a heat-sterilized, low-toxic and less acid fluid for peritoneal dialysis. Perit Dial Int. 1995;15:158-164.
6. Yang AH, Chen JY, Lin YP, Huang TP, Wu CW. Peritoneal dialysis solutions induce apoptosis of mesothelial cells. Kidney Int. 1997;51:1280-1288.
7. Witowski J, Bender TO, Gahl GM, Frei U, Jorres A. Glucose dcegradation Products and peritoneal membrane function. Perit Dial Int. 2001;21:201-205.
8. Amore A, Cappelli G, Cirina P, et al. Glucose degradation products increase apoptosis of human mesothelial cells. Nephrol Dial Transplant. 2003;18:677-688.
9. Stoenoiu MS, De Vriese AS, Brouet A, et al. Experimental diabetes induces functional and structural changes in the peritoneum. Kidney Int. 2002;62:668-678.
10. Ferrier ML, Combet S, van Landschoot M, et al. Inhibition of nitric oxide synthase reverse changes in peritoneal permeability in a rat model of acute peritonitis. Kidney Int. 2001;60:2343-2350.
11. Ni J, Moulin P, Gianello P, Feron O, Balligand JL, Devuyst O. Mice that lack nitric oxide synthase are protected against functional and structural modifications induced by acute peritonitis. J Am Soc Nephrol. 2003;14:3205-3216.